Literature DB >> 17617588

Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.

Stephen F Yates1, Alison M Paterson, Kathleen F Nolan, Stephen P Cobbold, Nigel J Saunders, Herman Waldmann, Paul J Fairchild.   

Abstract

Transplants tolerated through a process known as infectious tolerance evoke continuous recruitment of regulatory T (Treg) cells that are necessary to maintain the unresponsive state. This state is maintained long-term and requires continuous Ag exposure. It is not known, however, whether infectious tolerance operates through sustained recruitment of pre-existing regulatory cells, induction of regulatory cells, or both. Using mice deficient in natural Treg cells, we show here that quiescent donor dendritic cells (DC) laden with histocompatibility Ag can induce Treg cells de novo that mediate transplantation tolerance. In contrast, fully activated DC fail to do so. These findings suggest that DC incapable of delivering full activation signals to naive T cells may favor their polarization toward a regulatory phenotype. Furthermore, they suggest a role for quiescent endogenous DC in the maintenance of the tolerant state.

Entities:  

Mesh:

Year:  2007        PMID: 17617588     DOI: 10.4049/jimmunol.179.2.967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Tolerance: an overview and perspectives.

Authors:  Herman Waldmann
Journal:  Nat Rev Nephrol       Date:  2010-08-17       Impact factor: 28.314

Review 2.  The challenge of immunogenicity in the quest for induced pluripotency.

Authors:  Paul J Fairchild
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

3.  Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration.

Authors:  Katy Derbyshire; Caroline Addey; David Coe; Daniel W Stuckey; Hasan Muezzin; Jason A Bubier; Daniel J Shaffer; Derry C Roopenian; Jian-Guo Chai; Diane M Scott
Journal:  J Immunol       Date:  2011-04-13       Impact factor: 5.422

Review 4.  Special regulatory T-cell review: Regulation of immune responses--examining the role of T cells.

Authors:  Elizabeth Simpson
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

Review 5.  Regulatory T-cell therapy in transplantation: moving to the clinic.

Authors:  Qizhi Tang; Jeffrey A Bluestone
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

6.  Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination.

Authors:  Morteza Samadi-Foroushani; Rouhollah Vahabpour; Arash Memarnejadian; Afshin Namdar; Masoumeh Khamisabadi; Seyed Mehdi Sadat; Hossein Asgarian-Omran; Kayhan Azadmanesh; Parviz Kokhaei; Mohammad Reza Aghasadeghi; Jamshid Hadjati
Journal:  Med Oncol       Date:  2010-11-02       Impact factor: 3.064

7.  Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.

Authors:  Guerard W Byrne; Paul G Stalboerger; Eduardo Davila; Carrie J Heppelmann; Mozammel H Gazi; Hugh C J McGregor; Peter T LaBreche; William R Davies; Vinay P Rao; Keiji Oi; Henry D Tazelaar; John S Logan; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2008 Jul-Aug       Impact factor: 3.907

8.  IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.

Authors:  Heth R Turnquist; Tina L Sumpter; Allan Tsung; Alan F Zahorchak; Atsunori Nakao; Gerard J Nau; Foo Y Liew; David A Geller; Angus W Thomson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Pluripotent stem cells: immune to the immune system?

Authors:  Jeremy I Pearl; Leslie S Kean; Mark M Davis; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-12-12       Impact factor: 17.956

Review 10.  Tolerogenic dendritic cells: all present and correct?

Authors:  A W Thomson
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.